The National Center to Accelerate Cures (NCAC) today, October 1, 2026 announced its official launch as a national initiative dedicated to advancing ...
Annovis Bio, Inc., a Malvern, Pennsylvania-based Phase 3 clinical-stage biotech, announced on September 23, 2026 a collaboration with Weave Bio, an ...
SK pharmteco announced on September 22, 2026 an expanded manufacturing collaboration with Philadelphia-based Gemma Biotherapeutics ...
CTEM is designed to move biomedical research from the lab bench toward clinical application by putting Clark School of Engineering researchers and University of Maryland School of Medicine (UMSOM) ...
OS Therapies Aligns With FDA on Phase 3 Design, Accepts MHRA’s Project Orbis Invitation for OST-HER2
OS Therapies, Inc., a Rockville, Maryland- and New York-based clinical-stage oncology company, announced on September 17, 2026 that it has ...
Beltsville immuno-oncology company will cut a substantial majority of its workforce and shelve its pipeline as its Nasdaq listing becomes the vehicle for a $320 million, China-licensed inflammatory ...
Emergent BioSolutions Inc., headquartered in Gaithersburg, Maryland, announced on September 1, 2026 a contract modification valued at approximately $24 million for CYFENDUS® (Anthrax Vaccine Adsorbed, ...
ATCC, the Manassas, Virginia-based biological resource center, has been awarded a five-year, $7.3 million contract from the CDC to support influenza testing and surveillance work, under Contract ...
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results